Mira Care

Mira Care

The innovative woman's health company that supports fertility transparency and tracking technology is now available across Canada with the goal to bridge the fertility healthcare gap

SAN FRANCISCO, Aug. 20, 2026 /CNW/ -- Mira, the at-home, clinically-validated* hormone tracker, today announced its market expansion to English Canada. The monitoring system is trusted by 300,000+ women worldwide with the mission to help users understand their unique hormone patterns. Mira's lab-grade, FDA–registered and licensed by Health Canada, testing device provides quantitative hormone readings across the menstrual cycle to reduce the gap of fertility transparency. Mira's expansion into the Canadian market comes alongside its Class II Medical Device Licence from Health Canada and the company's success and trust over the past nine years in hormone and fertility monitoring, with over 60,000 reported pregnancies using Mira and up to 99.5% accuracy in hormone detection. Mira handheld testing wands and signature Ultra4 Kit are available for purchase across Canadian provinces here, with the exception of Quebec.

Originally published on the BLOX Digital Content Exchange.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.